Intrepid Potash, Inc.
IPIAbout the company
Intrepid Potash, Inc. delivers potassium, magnesium, sulfur, salt, and water products. It operates through three segments: Potash, Trio, and Oilfield Solutions. The company offers muriate of potash for various markets, such as in agricultural market as a fertilizer input, in animal feed market as a nutrient supplement, in industrial market as a component in drilling and fracturing fluids, as well as input to other industrial processes.
Investment snapshot
Positive
2
BUY / PASS
Neutral / negative
4 / 10
NEUTRAL / FAIL
Median fair value
$23.33
-29.1% vs price
Models with upside
0 / 17
Positive margin of safety
Strongest signal
10 of 12 pass โ Graham and Lynch object
Key risk
IPI overvalued: all 7 models price fair value below $32.91 (median $23.33)
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | FAIL ยท Rank #1706 (Top 55.1%) | NEUTRAL | FAIL | FAIL | FAIL | FAIL | NEUTRAL | FAIL | PASS | FAIL | BUY | FAIL | NEUTRAL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||
| Margin of Safety | -23.0% | -70.0% | N/A | N/A | N/A | N/A | -41.1% | -165.4% | -20.2% | N/A | -5.3% | -97.7% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history ยท FY 2025 ยท Balance sheet at 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history ยท FY 2025 ยท TTM ended 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history ยท FY 2025 ยท Balance sheet at 2026-09-30 ยท TTM ended 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history ยท FY 2025 Latest source filing: 2026-03-05 Score computed: 2026-11-14 | Annual history ยท FY 2025 Latest source filing: 2026-03-05 Score computed: 2026-11-14 | Annual history ยท FY 2025 ยท TTM ended 2026-09-30 ยท Balance sheet at 2026-09-30 ยท Market data at 2026-11-01 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Qualitative assessment ยท Annual history ยท FY 2025 ยท TTM ended 2026-09-30 ยท Balance sheet at 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Qualitative assessment ยท Annual history ยท FY 2025 Latest source filing: 2026-03-05 Score computed: 2026-11-14 | Annual history ยท FY 2025 ยท Qualitative assessment ยท Balance sheet at 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history ยท FY 2025 ยท TTM ended 2026-09-30 ยท Qualitative assessment Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history ยท FY 2025 ยท TTM ended 2026-09-30 ยท Balance sheet at 2026-09-30 ยท Market data at 2026-11-01 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history ยท FY 2025 ยท Price history 2025-01-01โ2026-11-01 ยท Balance sheet at 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history ยท FY 2025 ยท Qualitative assessment Latest source filing: 2026-03-05 Score computed: 2026-11-14 | TTM ended 2026-09-30 ยท Balance sheet at 2026-09-30 ยท Price history 2025-01-01โ2026-11-01 ยท Annual history ยท FY 2025 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history ยท FY 2025 ยท TTM ended 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history ยท FY 2025 ยท Balance sheet at 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history ยท FY 2025 ยท TTM ended 2026-09-30 ยท Price history 2025-01-01โ2026-11-01 Latest source filing: 2026-11-04 Score computed: 2026-11-14 |
Where It Passes
- Debt & Leverage83% passโ 13โ 2โพ
10 of 12 pass โ Graham and Lynch object
LT Debt vs Net Current AssetsโGrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.00, IC: 261.6xโBuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0โLynch< 0.33Cash - Long-term DebtโLynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%โPiotroskiDecreased YoYCurrent Assets / Current Liabilities5.96โDreman> 1.5โSchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0โDreman< 0.8โTempleton< 1.0 (fixed cap; proxy for below-sector-median leverage)โSchlossD/E < 1.00xDebt Levels0โMungerDebt/Equity < 0.5โAkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=261.6x, D/EBITDA=0.0xโMarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0โAckman<= 1.0Negative debt-to-equity (higher means less debt)-0.0038; #468/4210 (top 11.1%)โAsnessTop 30% of eligible cross-section - Cash Flow60% passโ 8โ 4โพ
6 of 10 pass โ Buffett, Lynch, Pabrai +1 more object
Free Cash Flow Proxy$21.5MโBuffettPositive and growingFCF Positive and Growing$25.5MโLynchPositive and growingOperating Cash Flow$55.8MโPiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=8.82%, ROA=1.77%โPiotroskiCFO/Assets > ROAPrice / (CFO / Shares)7.7xโDreman< 8xP/E or FCF YieldP/E=38.7x, FCF Yield=5.8%โPabraiP/E < 15 or FCF Yield > 10%FCF Positive10/17 years FCF positiveโMarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap6.2%โAckman>= 4%Price / FCF per Share16.9xโAckman<= 25Positive Operating Cash Flow frequency18/19 years positiveโSleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$26.8MโNeff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+6.10%; #1334/4519 (top 29.5%)โOshaughnessyTop 10% of eligible cross-section
Where It Falls Short
- Valuation models0% passโ 7โพ
IPI overvalued: all 7 models price fair value below $32.91 (median $23.33)
Graham fair value$26.75โGraham-23.0% margin vs $32.91Buffett fair value$19.36โBuffett-70.0% margin vs $32.91Munger fair value$23.33โMunger-41.1% margin vs $32.91Pabrai fair value$12.40โPabrai-165.4% margin vs $32.91Akre fair value$27.39โAkre-20.2% margin vs $32.91Ackman fair value$31.25โAckman-5.3% margin vs $32.91Templeton fair value$16.65โTempleton-97.7% margin vs $32.91 - Profitability13% passโ 8โ 27โพ
14 of 16 flag IPI's profitability โ Graham, Buffett, Lynch +11 more
Net income / market capitalization+5.52%; #1541/6340 (top 24.3%)โAsnessTop 30% of eligible cross-sectionโOshaughnessyTop 10% of eligible cross-sectionPositive EPS (10 years)11/22 years positiveโGrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)โGraham>= 33% growthNet Income Positive (10+ years)15/22 years positiveโBuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)-0.0%โBuffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)3.6% (latest)โBuffettStable or rising over 10 yearsFree Cash Flow Proxy$21.5MโBuffettPositive and growingEarnings Variance (10-yr CoV)โBuffettCoV < 0.3Retained Earnings EffectivenessโBuffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)P/E 38.7x (growth N/A)โLynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-53.8%โLynch15-30% (Fast Grower); > 0% to passROE4.7%โLynch> 15%EBIT / Enterprise Value3.0%โGreenblatt> 10%Earnings Yield + ROC AssessmentEY=3.0%, ROC=2.5%โGreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets1.77%โPiotroskiROA > 0ROA Change YoY-35.80% -> 1.77% (delta: +37.57%)โPiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=8.82%, ROA=1.77%โPiotroskiCFO/Assets > ROAGross Margin Change YoY11.4% -> 18.4%โPiotroskiImproved YoYPre-Tax Income / Revenue3.9%โDreman>= 8%Net Income / Shareholders' Equity4.7%โDreman> 12%Margin of SafetyP/E=38.7x, P/B=0.9xโPabraiP/B < 1.5 or P/E < 15Return on Equity-15.9% (3-yr avg)โAkreROE > 20% (3-year avg)Discount to Intrinsic ValueN/A (negative normalized EPS)โMarks>= 20% below intrinsic valuePositive Net Income Frequency15/21 years positiveโMarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue3.6%โAckman>= 15%Net Income / Shareholders Equity4.7%โAckman>= 15%5-Year EPS CAGR-53.8% CAGR over 4 yearsโTempleton> 0% (5-year EPS CAGR)Operating Margin Trend-15.8% (2023) -> 3.6% (2025)โTempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 13.2% -> 18.4%, operating margin -15.8% -> 3.6%โSleepRevenue rising; gross margin flat or falling; operating margin holdingGross profit / total assets+9.13%; #2857/3702 (top 77.2%)โAsnessTop 30% of eligible cross-sectionNet income / positive book equity+4.69%; #2493/5226 (top 47.7%)โAsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.2213; #4326/5884 (top 73.5%)โAsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR-53.8% over 4 yearsโNeff7%-20% annualizedPositive Diluted-EPS Years5/10 years positiveโSchloss>= 70% positive over 5-10 observed years (app rule) - Growth13% passโ 2โ 11โพ
7 of 8 flag IPI's growth โ Graham, Lynch, Dreman +4 more
EPS Growth (3-yr avg, 10-yr window)โGraham>= 33% growthBasic earnings-growth PEG (dividends excluded)P/E 38.7x (growth N/A)โLynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-53.8%โLynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -0.6% vs Rev: 17.1%โLynchInventory growth < Revenue growthEPS Growth DirectionโDremanPositive over recent yearsEPS CAGRโDreman> 5% annualizedPositive Net Income Frequency15/21 years positiveโMarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth4.2%โAckman>= 5%Positive EPS Growth Frequency2/5 years with positive EPS growthโAckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR-53.8% CAGR over 4 yearsโTempleton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 13.2% -> 18.4%, operating margin -15.8% -> 3.6%โSleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGRโSleepCAGR > 7%3-5 Year Diluted EPS CAGR-53.8% over 4 yearsโNeff7%-20% annualized - Valuation15% passโ 10โ 18โพ
11 of 13 flag IPI's valuation โ Graham, Lynch, Greenblatt +8 more
Price / Book Value per Share0.9xโDreman< 1.2xโTempleton< 1.5xโSchlossP/B <= 0.80x (app cutoff)Net income / market capitalization+5.52%; #1541/6340 (top 24.3%)โAsnessTop 30% of eligible cross-sectionโOshaughnessyTop 10% of eligible cross-sectionPrice / 3-yr avg EPSโGraham<= 15xPrice-to-Book Ratio0.9xโGraham<= 1.5xP/E x P/BโGraham<= 22.5Basic earnings-growth PEG (dividends excluded)P/E 38.7x (growth N/A)โLynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value3.0%โGreenblatt> 10%Earnings Yield + ROC AssessmentEY=3.0%, ROC=2.5%โGreenblattBoth EY > 10% and ROC > 25%Price / EPS38.7xโDreman< 12xโTempleton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)7.7xโDreman< 8xValuation ReasonablenessP/E=38.7x, OE Yield=5.0%โMungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=38.7x, FCF Yield=5.8%โPabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=38.7x, P/B=0.9xโMarksP/E < 15 or P/B < 2.0Discount to Intrinsic ValueN/A (negative normalized EPS)โMarks>= 20% below intrinsic valuePrice / FCF per Share16.9xโAckman<= 25Price vs. Trailing Low130% of trailing low ($25.30)โTempleton<= 120% of trailing low (certified split-adjusted live window)Positive book equity / market capitalization+1.1768; #1234/6449 (top 19.1%)โAsnessTop 30% of eligible cross-sectionPrice / Diluted EPS38.7xโNeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/EโNeff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share0.88xโSchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+18.7%โSchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.6783; #2244/5247 (top 42.8%)โOshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+6.10%; #1334/4519 (top 29.5%)โOshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-11.89%; #3538/6202 (top 57.0%)โOshaughnessyTop 10% of eligible cross-section - Verdicts15% passโ 2โ 11โพ
Split decision: 10 FAIL ยท 4 NEUTRAL ยท 1 PASS ยท 1 BUY
Overall verdictโGrahamFAIL (3/9)โBuffettFAIL (1/9)โLynchFAIL (2/7)โGreenblattRank #1706โขPiotroskiNEUTRAL (F-Score 7)โDremanFAIL (4/11)โMungerFAIL (1/4)โPabraiFAIL (1/3)โAkreFAIL (1/6)โขMarksNEUTRAL (4/5)โAckmanFAIL (3/9)โTempletonPASS (4/8)โSleepFAIL (1/6)โAsnessBUY (Rank #535/2370 (Top 22.6%))โNeffFAIL (2/6)โขSchlossNEUTRAL (4/7)โขOshaughnessyNEUTRAL (Not ranked) - Efficiency25% passโ 3โ 8โพ
6 of 8 flag IPI's efficiency โ Buffett, Greenblatt, Piotroski +3 more
Current Ratio5.96โGraham>= 2.0ROIC (3-5 yr avg)1.7%โBuffett> 10%ROIC - WACC-8.3%โBuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)2.5%โGreenblatt> 25%Current Ratio Change YoY4.84 -> 4.38โPiotroskiIncreased YoYRevenue / Total Assets Change YoY0.43x -> 0.47xโPiotroskiImproved YoYCurrent Assets / Current Liabilities5.96โDreman> 1.5Return on Invested Capital1.0%โMunger> 15%ROIC (high and growing)FY2023: ROIC=-5.0%; FY2024: ROIC=-3.3%; FY2025: ROIC=1.7%โAkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC1.7% (RR=100% x ROIC=1.7%)โAkreReinvestment Rate * ROIC > 10%ROIC (5-year)0/5 years above 12% (latest 1.7%)โSleepROIC > 12% in a majority of years
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Issued 1.7% of shares last year, 2.5% issued over two.
- Buybacks
- โ
- Dividends
- โ
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
Share count is the denominator the filer used for diluted EPS, recovered as net income รท EPS โ not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycleโs quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM ยท 2026-09-30 2025-10-01 โ 2026-09-30 Sources ยท derived quarter valuesDerived from cumulative filings: net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex. | Q3 FY 2026 2026-07-01 โ 2026-09-30 Sources ยท derived quarter valuesDerived from cumulative filings: operating cash flow, capex. | Q2 FY 2026 2026-04-01 โ 2026-06-30 Sources ยท derived quarter valuesDerived from cumulative filings: operating cash flow, capex. | Q1 FY 2026 2026-01-01 โ 2026-03-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $439.8Mcurrent | -- | -- | -- | $431.2Mest. | $339.4Mest. | $235.7Mest. | $415.3Mest. | $509.9Mest. |
| Revenue | -- | $51.0M | $66.7M | $98.7M | $298.3Mโ17% | $254.7Mโ9% | $279.1M | -- | -- |
| Operating Income | $6.5M | $209.0Kโ94% | $1.1Mโ68% | $6.2Mโ25% | $10.7Mโ154% | -$19.9Mโ55% | -$44.0Mโ146% | $95.4Mโ196% | $32.3M |
| Net Income | $24.3M | $1.7Mโ54% | $15.6Mโ377% | $7.4Mโ61% | $11.2Mโ105% | -$212.8Mโ497% | -$35.7Mโ149% | $72.2Mโ71% | $249.8M |
| EPS (Diluted) | -- | $0.13โ54% | $1.17โ368% | $0.56โ60% | $0.85โ105% | $-16.53โ490% | $-2.80โ152% | $5.37โ71% | $18.66 |
| Gross Margin | โ | 19.7% | 25.0% | 17.9% | 18.4%โ61% | 11.4%โ14% | 13.2% | โ | โ |
| Operating Margin | โ | 0.4% | 1.6% | 6.3% | 3.6%โ146% | -7.8%โ51% | -15.8% | โ | โ |
| ROE | 4.7% | โ | โ | โ | 2.3%โ105% | -44.9%โ761% | -5.2%โ152% | 10.1%โ73% | 37.7% |
| Total Debt | $2.0M | $2.0Mโ3% | $2.2Mโ66% | $2.4Mโ49% | $2.8Mโ192% | $951.0Kโ81% | $5.0M | $0 | $0 |
| Shareholders' Equity | $517.6M | $517.6Mโ5% | $515.2Mโ6% | $498.2Mโ4% | $491.4Mโ4% | $474.4Mโ31% | $684.4Mโ4% | $715.1Mโ8% | $663.4M |
| Current Ratio | 5.96 | 5.96โ14% | 6.33โ20% | 5.26โ2% | 4.38โ9% | 4.84โ48% | 3.27โ7% | 3.51โ64% | 2.14 |
| Debt / Equity | 0.00 | 0.00โ3% | 0.00โ56% | 0.00โ44% | 0.01โ182% | 0.00โ72% | 0.01 | 0.00 | 0.00 |
| Operating Cash Flow | $61.8M | -$4.6Mโ16% | $34.4Mโ14% | $23.2Mโ112% | $55.8Mโ23% | $72.5Mโ68% | $43.2Mโ51% | $88.8Mโ12% | $79.1M |
| Free Cash Flow | $26.8M | -$15.9Mโ36% | $25.9Mโ28% | $18.0Mโ582% | $25.5Mโ24% | $33.8Mโ255% | -$21.8Mโ208% | $20.1Mโ66% | $59.3M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Non-Metallic Mining
IPI vs Peers โ Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BHP Group LtdBHP | $202.0B | $79.49 | $51.3B | $9.0B | 18.9% | 0.45 | 38.0% | 1.46 | 1/9 | 6/9 | 2/7 | 1/3 | F-Score 5 | 7/11 |
| SOUTHERN COPPER CORP/SCCO | $140.0B | $164.08 | $13.4B | $4.3B | 39.4% | 0.61 | 52.2% | 3.89 | 4/9 | 5/9 | 4/7 | 1/3 | F-Score 7 | 5/11 |
| FREEPORT-MCMORAN INCFCX | $85.0B | $59.24 | $25.9B | $4.2B | 22.0% | 0.50 | 25.2% | 2.29 | 2/9 | 5/9 | 3/7 | 0/3 | F-Score 5 | 7/11 |
| Vale S.A.VALE | $47.7B | $11.22 | $38.4B | $2.4B | 7.0% | 0.02 | 15.4% | 1.15 | 1/9 | 4/9 | 2/7 | 1/3 | F-Score 3 | 4/11 |
| MARTIN MARIETTA MATERIALS INCMLM | $36.5B | $513.61 | $6.2B | $1.1B | 11.3% | 0.53 | 23.4% | 3.57 | 4/9 | 3/9 | 1/7 | 0/3 | F-Score 8 | 7/11 |
| Vulcan Materials COVMC | $35.8B | $278.63 | $7.9B | $1.1B | 12.6% | 0.51 | 20.4% | 2.69 | 2/9 | 2/9 | 2/7 | 0/3 | F-Score 9 | 5/11 |
| CAMECO CORPCCJ | $30.8B | $70.73 | $2.5B | $430.5M | 8.5% | 0.14 | 17.8% | 2.47 | 3/9 | 3/9 | 5/7 | 0/3 | F-Score 8 | 6/11 |
| TECK RESOURCES LTDTECK | $29.6B | $60.19 | $7.9B | $1.0B | 5.6% | 0.16 | 20.9% | 2.54 | 3/9 | 2/9 | 2/7 | 0/3 | F-Score 8 | 4/11 |